Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bayarmagnai Munkhjargal"'
Autor:
Otgonbayar Setevdorj, Bayarmagnai Munkhjargal, Ishdorj Tsedenish, Yerkyebulan Mukhtar, Khuderchuluun Nanjid, Sergelen Orgoi
Publikováno v:
Central Asian Journal of Medical Sciences, Vol 8, Iss 3, Pp 170-177 (2022)
Objectives: To assess the efficacy and safety of radiofrequency (RF) ablation versus surgery for benign thyroid nodules for 24 months period. Methods: From January 2019 to January 2021, 200 patients with nodular goiters who underwent surgery (group A
Externí odkaz:
https://doaj.org/article/80bb7e40c8794c11ae958dfb7008c9de
Autor:
Otgonbayar Setevdorj, Bayarmagnai Munkhjargal, Ishdorj Tsedenish, Yerkyebulan Mukhtar, Sergelen Orgoi
Publikováno v:
Central Asian Journal of Medical Sciences, Vol 8, Iss 1, Pp 39-47 (2022)
Objectives: To assess the efficacy and safety of thyroid radiofrequency (RF) ablation for benign thyroid nodules for a 24 months period. Methods: From 2019 to 2021, 485 nodules were from 183 patients (mean age 47.7 ± 11.2) who met eligibility criter
Externí odkaz:
https://doaj.org/article/e1be819f0a264a38a62279e9b70ec1a3
Autor:
Otgonbayar Setevdorj, Bayarmagnai Munkhjargal, Ishdorj Tsedenish, Yerkyebulan Mukhtar , Khuderchuluun Nanjid and Sergelen Orgoi
Objectives:Multinodular goiter is the most common thyroid disease in Mongolia. Recent guidelines suggest that a nodule without clinical symptoms should be treated with watchful waiting however, some patients require treatment because of cosmetic prob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e6e502cbedc8ac1261dfcf7b55d4d0
Autor:
Bayarmagnai Munkhjargal
Evidence related to whether any effective drug may prevent the occurrence of MINS in the postoperative setting is still lacking. Therefore, we propose a randomized, single-center, two-arm (1:1 ratio), active-controlled, double-dummy, phase II trial o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4382e235a0515bd0dc3ffb1a1730a52e